While all treatments demonstrated a small trend to lower COX-2 protein levels, no significant differences were observed ( p = N.S., Figure 7 A).
← all excerpts
The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.
2
—
—
The sentences
In contrast, the post-treatment group Psi + Eug (1:20) + LPS significantly lowered IL-1β levels compared to the LPS group ( p < 0.05), while other psilocybin and eugenol post-treatment combination (1:10 and 1:50) groups showed a trend to lower IL-1β levels, but this was not significant ( p = N.S., Figure 7 B). 2.2.4.